相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Evolving classification of rhabdomyosarcoma
Narasimhan P. Agaram
HISTOPATHOLOGY (2022)
Diagnosis of soft tissue tumors using immunohistochemistry as a surrogate for recurrent fusion oncoproteins
Margaret A. Black et al.
SEMINARS IN DIAGNOSTIC PATHOLOGY (2022)
Immunohistochemical detection of PAX-FOXO1 fusion proteins in alveolar rhabdomyosarcoma using breakpoint specific monoclonal antibodies
David O. Azorsa et al.
MODERN PATHOLOGY (2021)
Nuclear expression of DDIT3 distinguishes high-grade myxoid liposarcoma from other round cell sarcomas
Esther Baranov et al.
MODERN PATHOLOGY (2021)
OLIG2 is a marker of the fusion protein-driven neurodevelopmental transcriptional signature in alveolar rhabdomyosarcoma
Shyam S. Raghavan et al.
HUMAN PATHOLOGY (2019)
OLIG2 is a novel immunohistochemical marker associated with the presence of PAX3/7-FOXO1 translocation in rhabdomyosarcomas
Magdalena Kaleta et al.
DIAGNOSTIC PATHOLOGY (2019)
PAX3-FOXO1 Establishes Myogenic Super Enhancers and Confers BET Bromodomain Vulnerability
Berkley E. Gryder et al.
CANCER DISCOVERY (2017)
The Role of Forkhead Box 1 (FOXO1) in the Immune System: Dendritic Cells, T Cells, B Cells, and Hematopoietic Stem Cells
Adriana Alicia Cabrera-Ortega et al.
CRITICAL REVIEWS IN IMMUNOLOGY (2017)
Myogenin, AP2β, NOS-1, and HMGA2 Are Surrogate Markers of Fusion Status in Rhabdomyosarcoma A Report From the Soft Tissue Sarcoma Committee of the Children's Oncology Group
Erin R. Rudzinski et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2014)
PAX-FOXO1 fusion status drives unfavorable outcome for children with rhabdomyosarcoma: A children's oncology group report
Stephen X. Skapek et al.
PEDIATRIC BLOOD & CANCER (2013)
MUC4 Is a Sensitive and Extremely Useful Marker for Sclerosing Epithelioid Fibrosarcoma Association With FUS Gene Rearrangement
Leona A. Doyle et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
PAX3/FOXO1 Fusion Gene Status Is the Key Prognostic Molecular Marker in Rhabdomyosarcoma and Significantly Improves Current Risk Stratification
Edoardo Missiaglia et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
MUC4 Is a Highly Sensitive and Specific Marker for Low-grade Fibromyxoid Sarcoma
Leona A. Doyle et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification
T Hosaka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Abnormal angiogenesis in Foxo1 (Fkhr)-deficient mice
T Furuyama et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma
FG Barr
ONCOGENE (2001)
Are myogenin and MyoD1 expression specific for rhabdomyosarcoma? A study of 150 cases, with emphasis on spindle cell mimics
MH Cessna et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2001)
Myogenin is a specific marker for rhabdomyosarcoma: An immunohistochemical study in paraffin-embedded tissues
S Kumar et al.
MODERN PATHOLOGY (2000)
分享论文
